Submitted to: American Veterinary Medical Association Abstract
Publication Type: Abstract Only
Publication Acceptance Date: 10/1/1998
Publication Date: N/A
Citation: Cray, P.J., Dargatz, D.A., Wells, S.J., Wineland, N.E., Miller, M.A., Tollefson, L., Petersen, K.E. 1999. Impact of antimicrobic use in veterinary medicine. American Veterinary Medical Association Abstract. 213 (12) P. 1739-1741.
Technical Abstract: Antimicrobial resistance is a global concern for human and animal health. Expert scientific roups such as the Institute of Medicine, the American Society for Microbiology, and the World Health Organization expressed apprehension about the national and global increase in antibiotic resistance and the complex issues surrounding the increase of antimicrobial resistance in community and institutional settings. Because of public health concerns associated with the use of antimicrobics in food animals, an antimicrobial resistance monitoring program was proposed by the FDA Center for Veterinary Medicine (FDA-CVM) as a postmarketing activity to help ensure the continued safety and efficacy of veterinary antimicrobics, especially fluoroquinolones. In 1996, the Centers for Disease Control (CDC), United Stated Department of Agriculture (USDA), and FDA- CVM established the National Antimicrobial Resistance Monitoring System (previously referred to as the National Antimicrobial Susceptibility Monitoring Program) to prospectively monitor changes in antimicrobial susceptibility of zoonotic pathogens in specimens obtained from ill humans and animals, healthy farm animals, and carcasses of animals at slaughter. Non-typhoid Salmonella was selected as the sentinel organism.